Kaurenoic acidCAS# 6730-83-2 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 6730-83-2 | SDF | Download SDF |
PubChem ID | 73062 | Appearance | White powder |
Formula | C20H30O2 | M.Wt | 302.46 |
Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
Synonyms | Cunabic acid | ||
Solubility | Soluble in DMSO and methan | ||
SMILES | CC12CCCC(C1CCC34C2CCC(C3)C(=C)C4)(C)C(=O)O | ||
Standard InChIKey | NIKHGUQULKYIGE-OTCXFQBHSA-N | ||
Standard InChI | InChI=1S/C20H30O2/c1-13-11-20-10-7-15-18(2,16(20)6-5-14(13)12-20)8-4-9-19(15,3)17(21)22/h14-16H,1,4-12H2,2-3H3,(H,21,22)/t14-,15+,16+,18-,19-,20-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Kaurenoic acid has anti-inflammatory, analgesic, antimicrobial, cytotoxic and embryotoxic effects; it exerts a uterine relaxant effect acting principally through calcium blockade and in part, by the opening of ATP-sensitive potassium channels. Kaurenoic acid involves the inhibition of cytokine production and activation of the NO-cyclic GMP-protein kinase G-ATP-sensitive potassium channel signaling pathway. |
Targets | NO | PGE | COX | NOS | NF-kB | ATP | GMP |
In vitro | Kaurenoic Acid from Aralia continentalis Inhibits Biofilm Formation of Streptococcus mutans.[Pubmed: 23662113]Evid Based Complement Alternat Med. 2013;2013:160592.We isolated a single chemical compound from A. continentalis and identified it to be Kaurenoic acid (KA) and investigated the influence of anticariogenic properties.
|
In vivo | Anticonvulsant effect of kaurenoic acid isolated from the root bark of Annona senegalensis.[Pubmed: 23664900]Pharmacol Biochem Behav. 2013 Aug;109:38-43.The herbal preparations of Annona senegalensis Pers. (Annonaceae) root bark are used in Nigerian ethnomedicine for the treatment of epilepsy and febrile seizures. The scientific evidence for this effect has been reported.
The aim of this study was to identify and characterize the active constituent responsible for the anticonvulsant effect.
Inhibitory effects of kaurenoic acid from Aralia continentalis on LPS-induced inflammatory response in RAW264.7 macrophages.[Pubmed: 21211951]Phytomedicine. 2011 Jun 15;18(8-9):677-82.This study investigates the anti-inflammatory effects of a diterpenoid, Kaurenoic acid, isolated from the root of Aralia continentalis (Araliaceae). |
Cell Research | The epimer of kaurenoic acid from Croton antisyphiliticus is cytotoxic toward B-16 and HeLa tumor cells through apoptosis induction.[Pubmed: 23613246]Genet Mol Res. 2013 Apr 2;12(2):1005-11.Cancer has become the leading cause of death in developing countries due to increased life expectancy of the population and changes in lifestyle. Studies on active principles of plant have motivated researchers to develop new antitumor agents that are specific and effective for treatment of neoplasms.
Kaurane diterpenes are considered important compounds in the development of new and highly effective anticancer chemotherapeutic agents due to their cytotoxic properties in the induction of apoptosis.
|
Kaurenoic acid Dilution Calculator
Kaurenoic acid Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.3062 mL | 16.5311 mL | 33.0622 mL | 66.1244 mL | 82.6556 mL |
5 mM | 0.6612 mL | 3.3062 mL | 6.6124 mL | 13.2249 mL | 16.5311 mL |
10 mM | 0.3306 mL | 1.6531 mL | 3.3062 mL | 6.6124 mL | 8.2656 mL |
50 mM | 0.0661 mL | 0.3306 mL | 0.6612 mL | 1.3225 mL | 1.6531 mL |
100 mM | 0.0331 mL | 0.1653 mL | 0.3306 mL | 0.6612 mL | 0.8266 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 2-Hydroxy-4-methoxybenzaldehyde
Catalog No.:BCN7798
CAS No.:673-22-3
- H-Asp(OtBu)-OMe.HCl
Catalog No.:BCC2892
CAS No.:2673-19-0
- H-D-Phe-OH
Catalog No.:BCC3012
CAS No.:673-06-3
- Kansuinine E
Catalog No.:BCN3769
CAS No.:672945-84-5
- 3-O-(2'E ,4'Z-decadienoyl)-20-deoxyingenol
Catalog No.:BCN1382
CAS No.:672941-64-9
- Kif15-IN-2
Catalog No.:BCC5153
CAS No.:672926-33-9
- Kif15-IN-1
Catalog No.:BCC5152
CAS No.:672926-32-8
-
γDGG
Catalog No.:BCC6557
CAS No.:6729-55-1
- SKF 83959 hydrobromide
Catalog No.:BCC7251
CAS No.:67287-95-0
- SKF 81297 hydrobromide
Catalog No.:BCC7071
CAS No.:67287-39-2
- Cabraleadiol
Catalog No.:BCN4224
CAS No.:67253-01-4
- Boc-MLF
Catalog No.:BCC6061
CAS No.:67247-12-5
- 1,3,5-Trihydroxyxanthone
Catalog No.:BCN3357
CAS No.:6732-85-0
- Hexa-D-arginine
Catalog No.:BCC6269
CAS No.:673202-67-0
- (R,R)-Formoterol
Catalog No.:BCC1293
CAS No.:67346-49-0
- Pterokaurane R
Catalog No.:BCN4076
CAS No.:67349-43-3
- Catalposide
Catalog No.:BCN4225
CAS No.:6736-85-2
- Drospirenone
Catalog No.:BCC4493
CAS No.:67392-87-4
- H-D-Lys-OMe.2HCl
Catalog No.:BCC2680
CAS No.:67396-08-1
- 3-O-Acetyl-11-keto-beta-boswellic acid
Catalog No.:BCN1381
CAS No.:67416-61-9
- Z-D-His-OH
Catalog No.:BCC2767
CAS No.:67424-93-5
- (±)-Blebbistatin
Catalog No.:BCC7169
CAS No.:674289-55-5
- Isorhamnetin-3-O-galactoside
Catalog No.:BCC8190
CAS No.:6743-92-6
- Fmoc-Cys(tBu)-OH
Catalog No.:BCC3478
CAS No.:67436-13-9
Kaurenoic Acid from Aralia continentalis Inhibits Biofilm Formation of Streptococcus mutans.[Pubmed:23662113]
Evid Based Complement Alternat Med. 2013;2013:160592.
We isolated a single chemical compound from A. continentalis and identified it to be Kaurenoic acid (KA) and investigated the influence of anticariogenic properties. Inhibitory effects of KA on cariogenic properties such as growth, acid production, biofilm formation, and the adherence of S. mutans were evaluated. Furthermore, real-time PCR analysis was performed to evaluate the influence of KA on the genetic expression of virulence factors. KA significantly inhibited the growth and acid production of S. mutans at 2-4 mu g/mL and 4 mu g/mL of KA, respectively. Furthermore, the adherence onto S-HAs was inhibited at 3-4 mu g/mL of KA and biofilm formation was significantly inhibited when treated with 3 mu g/mL KA and completely inhibited at 4 mu g/mL. Also, the inhibitory effect of KA on biofilm formation was confirmed by SEM. In confocal laser scanning microscopy, bacterial viability gradually decreased by KA in a dose dependent manner. Real-time PCR analysis showed that the expressions of gtfB, gtfC, gbpB, spaP, brpA, relA, and vicR were significantly decreased in S. mutans when it was treated with KA. These results suggest that KA from A. continentalis may be a useful agent for inhibiting the cariogenic properties of S. mutans.
Inhibitory effects of kaurenoic acid from Aralia continentalis on LPS-induced inflammatory response in RAW264.7 macrophages.[Pubmed:21211951]
Phytomedicine. 2011 Jun 15;18(8-9):677-82.
This study investigates the anti-inflammatory effects of a diterpenoid, Kaurenoic acid, isolated from the root of Aralia continentalis (Araliaceae). To determine its anti-inflammatory effects, LPS-induced RAW264.7 macrophages were treated with different concentrations of Kaurenoic acid and carrageenan-induced paw edema mice model was used in vivo. Kaurenoic acid (ent-kaur-16-en-19-oic acid) dose-dependently inhibited nitric oxide (NO) production, prostaglandin E(2) (PGE(2)) release, cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression at micromolar concentrations in LPS-induced RAW264.7 macrophages with IC(50) (the half maximal inhibitory concentration) values of 51.73 (+/-2.42) muM and 106.09 (+/-0.27) muM in NO production and PGE(2) release, respectively. Kaurenoic acid also dose-dependently inhibited LPS-induced activation of NF-kappaB as assayed by electrophorectic mobility shift assay (EMSA) and it almost abolished NF-kappaB DNA binding affinity at 100muM. Furthermore, the in vivo anti-inflammatory effect of Kaurenoic acid was examined in a carrageenan-induced paw edema model. Eight ICR mice in each group were injected with carrageenan and observed hourly, compared with the control group. Kaurenoic acid dose-dependently reduced paw swelling up to 34.4% at 5h after induction, demonstrating inhibition in an acute inflammation model. Taken together, our data suggest that Kaurenoic acid, a major diterpenoid from the root of A. continentalis shows anti-inflammatory activity and the inhibition of iNOS and COX-2 expression might be one of the mechanisms responsible for its anti-inflammatory properties.
Anticonvulsant effect of kaurenoic acid isolated from the root bark of Annona senegalensis.[Pubmed:23664900]
Pharmacol Biochem Behav. 2013 Aug;109:38-43.
CONTEXT: The herbal preparations of Annona senegalensis Pers. (Annonaceae) root bark are used in Nigerian ethnomedicine for the treatment of epilepsy and febrile seizures. The scientific evidence for this effect has been reported. OBJECTIVE: The aim of this study was to identify and characterize the active constituent responsible for the anticonvulsant effect. MATERIALS AND METHODS: Bioactive-guided fractionation of the methanol-methylene chloride root bark extract (MME) of A. senegalensis using pentylenetetrazole (PTZ)-induced seizures in mice, afforded a potent anticonvulsant ethyl-acetate fraction (EF). Further fractionation of the EF yielded eight sub-fractions (F(1)-F(8)) which were tested for anticonvulsant activity. The sub-fraction F(2) yielded white crystals that were purified to obtain A. senegalensis crystals, AS2. The AS2, which exhibited potent anticonvulsant effects, was characterized by 1D and 2D NMR spectroscopy, mass spectroscopy and X-ray crystallography. RESULTS: The AS2 was characterized as kaur-16-en-19-oic acid (KA), a diterpenoid. The AS2 indicated an oral LD(5)(0) of 3800 mg/kg. The results showed that the MME, EF and AS2 significantly (P<0.05) and dose-dependently delayed the onset of myoclonic spasms and tonic-clonic phases of seizures induced by PTZ and maximal electroshock seizures (MES). DISCUSSION AND CONCLUSION: Kaurenoic acid was identified as the anticonvulsant principle in the root bark extract of A. senegalensis. The anticonvulsant effect of the MME, EF and AS2 is most likely being mediated through central inhibitory mechanisms.
The epimer of kaurenoic acid from Croton antisyphiliticus is cytotoxic toward B-16 and HeLa tumor cells through apoptosis induction.[Pubmed:23613246]
Genet Mol Res. 2013 Apr 2;12(2):1005-11.
Cancer has become the leading cause of death in developing countries due to increased life expectancy of the population and changes in lifestyle. Studies on active principles of plant have motivated researchers to develop new antitumor agents that are specific and effective for treatment of neoplasms. Kaurane diterpenes are considered important compounds in the development of new and highly effective anticancer chemotherapeutic agents due to their cytotoxic properties in the induction of apoptosis. We evaluated the cytotoxic and apoptotic activity of the epimer of Kaurenoic acid (EKA) isolated from the medicinal plant Croton antisyphiliticus (Euphorbiaceae) toward tumor cell lines HeLa and B-16 and normal fibroblasts 3T3. Based on analyses with the MTT test, EKA showed cytotoxic activity, with half maximal inhibitory concentration values of 59.41, 68.18 and 60.30 microg/mL for the B-16, HeLa and 3T3 cell lines, respectively. The assay for necrotic or apoptotic cells by differential staining showed induction of apoptosis in all three cell lines. We conclude that EKA is not selective between tumor and normal cell lines; the mechanism of action of EKA is induction of apoptosis, which is part of the innate mechanism of cell defense against neoplasia.